Sectors
AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.
Uqar spinout Ovensa has obtained $1.38m of additional funding from investors including commercialisation firm Aligo Innovation.
Intel and New Enterprise Associates have co-led a series A round for computer vision startup Matroid, based on research by Stanford professor Reza Zadeh.
WuXi Healthcare Ventures has led a first funding round for LifeMine Therapeutics, based on research by Harvard University profressor Gregory Verdine.
Imstem Biotechnology, a spinout from Connecticut, has won a patent for its stem cell-based treatment of autoimmune diseases such as multiple sclerosis.
IBM and MIT have inked a $240m research venture aimed at developing artificial intelligence technologies over a 10-year term.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
